Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

Conditions: Peritoneal Neoplasms|Retroperitoneal Neoplasms|Gastrointestinal Neoplasms|Adenocarcinoma|Neuroblastoma|Ovarian Neoplasms|Sarcoma|Adrenocortical Carcinoma|Wilms Tumor|Rhabdomyosarcoma|Desmoplastic Small Round Cell Tumor
Start Date: February 1, 2007
Phase: Phase I
Status: Active, not recruiting
NCT ID: NCT00436657
Study Type: Interventional
Intervention: Drug: CHPP of Cisplatin|Procedure: Abdominal Surgery
Study Design: Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: M.D. Anderson Cancer Center
Ages: Child|Adult
Enrollment: 18
Funded By: Other
First Received: February 15, 2007
End Date:
Last Updated: September 30, 2010
Last Verified: September 1, 2010

Mesothelioma
Lawsuit Evaluation

First Name
Last Name
Phone Number
Email
Zip Code
Details:
Please Include Diagnosis Date
Type The Number Below: